Tatiana S. Prokhorenko

Tatiana S. Prokhorenko

Auto-generated profile, based on publicly available information

Tatiana S. Prokhorenko

Siberian State Medical University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Nadezhda MusinaNadezhda Musina
Nadezhda Musina
TSTatiana Saprina
Tatiana Saprina
TPTatiana S. Prokhorenko
Tatiana S. Prokhorenko
AKAleksandr Kanev
Aleksandr Kanev
AZAnastasia P. Zima
Anastasia P. Zima
This study aims to establish relationships between inflammatory status, ferrokinetics and lipid metabolism in patients with diabetes mellitus. Subclinical inflammation was assessed by levels of high-sensitive C-reactive protein, tumor necrosis factor-α and erythrocyte sedimentation rate. Iron metabolism parameters included complete blood count, serum iron, transferrin and ferritin. Metabolic status assessment included lipid profile, glycated hemoglobin and microalbuminuria measurement. As a result of the study it was possible to establish both general (universal) and diabetes mellitus (DM) type-dependent relationships between the parameters of lipid profile and metabolic control in DM. High-density lipoprotein cholesterol (HDL-C) levels negatively correlated with microalbuminuria (r = −0.293; p ˂ 0.05 for type 1 diabetes and r = −0.272; p ˂ 0.05 for type 2 diabetes). Ferritin concentration positively correlated with triglyceride level (r = 0.346; p ˂ 0.05 for type 1 diabetes and r = 0.244; p ˂ 0.05 for type 2 diabetes). In type 1 diabetes, a negative correlation was discovered between estimated glomerular filtration rate (eGFR) and LDL-C (r = −0.480; p ˂ 0.05), very low-density-lipoprotein cholesterol (VLDL-C) (r = −0.490; p ˂ 0.05) and triglycerides (r = −0.553; p ˂ 0.05), and a positive one between C-reactive protein concentration and triglyceride level (r = 0.567; p ˂ 0.05). Discovered relationships between lipid profile indices, inflammatory status and microalbuminuria confirmed mutual influence of hyperlipidemia, inflammation and nephropathy in diabetes patients. Obtained results justify the strategy of early hypolipidemic therapy in patients with diabetes mellitus to prevent the development and progression of microvascular complications.

29 December 2018 in Diabetes mellitus
Verified
Journal Article
Open access
TSTatiana Saprina
Tatiana Saprina
AZAnastasia P. Zima
Anastasia P. Zima
Nadezhda MusinaNadezhda Musina
Nadezhda Musina
TPTatiana S. Prokhorenko
Tatiana S. Prokhorenko
ALAlina V. Latypova
Alina V. Latypova
SBSvetlana V. Budeeva
Svetlana V. Budeeva
Hepcidin, a hormone regulating iron metabolism, has received attention for its role in the pathogenesis of dysregulations in carbohydrate metabolism. Hepcidin disorders in patients with diabetes mellitus are bi-directional: manifesting as iron overload syndrome in cases of decreased hepcidin production and as anaemia of chronic disease in cases of hepcidin hypersecretion. However, till date, detailed analyses of mechanisms underlying hepcidin dysregulation have not been conducted nor have the interactions of ferrocinetic and carbohydrate-metabolic disorders been examined. An association between diabetes mellitus and neurodegenerative diseases as well as the role of iron metabolism in Alzheimer or Parkinson diseases is a subject of ongoing research. This review provides a summary of the current understanding of hepcidin regulation and its disorders in various diseases, including diabetes mellitus and neurodegenerative diseases. In addition, we provide an overview of the available therapies that address ferrocinetic disorders resulting from the dysregulation of hepcidin.

14 November 2023 in Obesity and metabolism
Verified
Journal Article
Open access
PDF file
Nadezhda MusinaNadezhda Musina
Nadezhda Musina
YSYa. S. Slavkina
Ya. S. Slavkina
DPD. A. Petrukhina
D. A. Petrukhina
AZA. P. Zima
A. P. Zima
TPT. S. Prokhorenko
T. S. Prokhorenko
TSTatiana Saprina
Tatiana Saprina
Iron affects the pathogenesis and clinical course of several chronic metabolic diseases such as obesity, atherosclerosis, non-alcoholic fatty liver disease and type 2 diabetes mellitus. High pro-oxidant iron activity is physiologically controlled by mechanisms regulating entry, recycling, and loss of body iron. These mechanisms include the interplay of iron with ferritin, transferrin, hepcidin, insulin, as well as with adipokines and proinflammatory molecules. An imbalance of these regulatory mechanisms results in both systemic and parenchymal siderosis. Iron overload has a toxic effect on the major tissues involved in lipid and glucose metabolism — pancreatic β cells, liver, muscle, and adipose tissue — as well as the organs affected by chronic hyperglycemia — brain, retina and kidneys. Hyperferremia leads to a decrease in insulin secretion, the formation of insulin resistance and increased liver gluconeogenesis. Molecular mechanisms for these effects are diverse. Elucidating them will implicate both for carbohydrate metabolism disorders prevention and for the pathogenesis of other diseases that are, like diabetes mellitus type 2, associated with nutrition, aging and iron. The literature review presents data from world studies on the mutual influence of glucose metabolism and iron overload, and discusses the differences between hereditary and acquired disorders of iron metabolism from the standpoint of their influence on carbohydrate metabolism.

15 May 2023 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
TSTatiana Saprina
Tatiana Saprina
Nadezhda MusinaNadezhda Musina
Nadezhda Musina
TPT. S. Prokhorenko
T. S. Prokhorenko
YSYa. S. Slavkina
Ya. S. Slavkina
AZA. P. Zima
A. P. Zima
BACKGROUND: High prevalence of anemia in diabetes mellitus (DM) determines the relevance of studying its pathogenetic aspects, the role of anemia in DM complications development and the issue of differential diagnosis between iron deficiency anemia (IDA) and anemia of chronic disease (ACD)).AIM: To establish the diagnostic value of classical parameters for diagnosing anemia in DM and propose an optimized algorithm for the differential diagnosis of ACD and IDA in DM type 1 and 2 using new markers.MATERIALS AND METHODS: The observational, single-centre, comparative, controlled, single-stage study. Patients underwent assessment of glycated hemoglobin, creatinine, microalbuminuria; indicators of iron metabolism — hematocrit, the number of erythrocytes, reticulocytes, hemoglobin, serum iron, transferrin, ferritin, the level of soluble transferrin receptors (sTfR), sTfR/logFerpitin index, and inflammation markers — erythrocyte sedimentation rate (ESR), leukocyte count, high sensitive CRP and TNF-α. ROC-analysis was used to assess the differential diagnosis markers informative content.RESULTS: We examined 135 patients: 51 with DM 1 and 84 with DM 2. The patients were stratified into groups based on anemia type: 1) ACD 2) IDA 3) latent iron deficiency 4) without ferrokinetics disorders. According to the ROC-analysis in DM patients, the following parameters had high information content in ACD. ESR — sensitivity 92%, specificity 85%, diagnostic threshold 26.5 mm/h (area under the curve (AUC) 0.943; p<0.0001); leukocyte count — sensitivity 69%, specificity 64%, diagnostic threshold 7.50x109/l (AUC 0.727; p=0.007), microalbuminuria — sensitivity 71%, specificity 72%, diagnostic threshold 29.5 mg/l (AUC 0.744; p=0.003). In DM sTfR and the sTfR /logFerritin index had high information content in IDA at diagnostic thresholds different from those for general population. The sensitivity of sTfR 71%, the specificity 71%, diagnostic threshold 1.42 ng/mL (2.9 ng/mL for general population) (AUC 0.765; p=0.024). The sensitivity of sTfR/logFerritin index 100%, the specificity 97%, diagnostic threshold 1.48 (2.0 for general population) (AUC 0.983; p=0.024).CONCLUSION: In differential diagnosis of IDA and ACD in DM, ESR, leukocyte count, microalbuminuria, sTfR and sTfR/logFerritin index have a high diagnostic value. This allows proposing them as additional markers for differential diagnosis of anemia in DM.

1 January 2017 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
TPT. S. Prokhorenko
T. S. Prokhorenko
AЗArray П. Зима
Array П. Зима
TST. V. Saprina
T. V. Saprina
NMN. N. Musina
N. N. Musina
NSN. S. Shakhmanova
N. S. Shakhmanova
VNV. V. Novitsky
V. V. Novitsky
В обзоре раскрывается проблема дифференциальной диагностики микроцитарных гипохромных анемий у беременных с нарушением углеводного обмена при использовании существующего лабораторного алгоритма обследования. Приводятся данные о неоднородности структуры анемического синдрома у женщин с сахарным диабетом 1-го типа. Особое внимание уделяется описанию роли гепсидина в метаболизме железа и механизмов регуляции его продукции в норме и при патологии. Приводятся ссылки на результаты исследований, подтверждающих целесообразность включения гепсидина в алгоритмы дифференциальной диагностики различных видов анемического синдрома. Затрагивается вопрос терапии анемии хронических заболеваний.

1 January 2017 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
TPT. S. Prokhorenko
T. S. Prokhorenko
AЗArray П. Зима
Array П. Зима
TSTatiana Saprina
Tatiana Saprina
VNV. V. Novitskiy
V. V. Novitskiy
NTNatalia Todosenko
Natalia Todosenko
LLLarisa Litvinova
Larisa Litvinova
Методом проточной флюориметрии с использованием мультиплексной тест-системы проведено определение концентрации цитокинов (IL-2, IL-6, IL-8, IL-10, GM-CSF, IFNγ, TNFα) в сыворотке крови беременных в зависимости от вида метаболических нарушений: при гестационном сахарном диабете, ожирении и их сочетании. Изменение цитокинового профиля у беременных с избыточной массой тела или ожирением и беременных с гестационныи сахарным диабетом оказалось значительно схожим. У беременных, имеющих избыточный вес или ожирение, выявлено повышение концентрации в крови IL-2, IL-6, IL-10, IFNγ и TNFα; у беременных с гестационным сахарным диабетом – повышение содержания в крови IL-2, IL-6, IL-10 и TNFα. При беременности, отягощенной гестационным сахарным диабетом и ожирением, изменения цитокинового профиля носили наиболее выраженный характер. У данных женщин определена повышенная концентрация в крови IL-6, TNFα, GM-CSF и IFNγ на фоне низкого содержания IL-2 и IL-10. Обсуждаются причины и последствия развития у беременных субклинического воспаления. Дается заключение, что у беременных с метаболическими нарушениями субклиническое воспаление развивается с ранних стадий ожирения или нарушения углеводного обмена.